Media

Corgentech to Announce Fourth Quarter and Year-End 2005 Financial Results and Host Webcast Conference Call on February 23, 2006

SOUTH SAN FRANCISCO, Calif., Feb 17, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, will announce financial results for the fourth quarter and year-end 2005 after the markets close on Thursday, February 23, 2006 and will hold a webcast teleconference at 4:30 p.m. EST that day. Members of Corgentech's management team will discuss financial results from the fourth quarter and full year 2005 as well as provide an overview of the company's product pipeline and projected milestones for 2006.

Interested parties can listen to the live audio webcast, or the subsequent archived recording, by logging on to www.corgentech.com and going to the Investor Information page. Please connect to Corgentech's website several minutes prior to the start of the conference call to ensure adequate time for any software download that may be necessary. For those unable to participate via the Internet, a 24-hour replay will be available for seven days after the call by calling 800-642-1687 (international dial: 706-645-9291) and giving the following pass code: 5359384. The webcast will be available until the company's next quarterly financial results conference call.

About Corgentech

Corgentech is a late-stage biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for pain and inflammation. The company has four drug candidates in clinical development for multiple potential indications, the most advanced of which, ALGRX 3268, has completed Phase 3 clinical trials. Corgentech is based in South San Francisco, CA. For more information on the company, please visit www.corgentech.com.

SOURCE Corgentech Inc.

Jennifer Cook Williams, Vice President, Investor Relations, of Corgentech Inc.,
+1-650-624-9600, or [email protected]

http://www.prnewswire.com

News Provided by COMTEX